
Number of publications published per year by Indraccolo, Stefano. (Source : PubMed)

Distribution of publications types for Indraccolo, Stefano. (Source : PubMed)
(a publication can be of different types, so total may exceed publications count)
Interferon-alpha as angiogenesis inhibitor: Learning from tumor models.
Autoimmunity
2010

Side population and cancer stem cells: therapeutic implications.
Cancer Lett.
2010;288;1
Ligand-driven activation of the notch pathway in T-ALL and solid tumors: why Not(ch)?
Cell Cycle
2010;9;1
Heat-induced transcription of diphtheria toxin A or its variants, CRM176 and CRM197: implications for pancreatic cancer gene therapy.
Cancer Gene Ther.
2010;17;1
Impact of VEGF-dependent tumour micro-environment on EDB fibronectin expression by subcutaneous human tumour xenografts in nude mice.
J. Pathol.
2009;219;4

Antineoplastic activity of lentiviral vectors expressing interferon-alpha in a preclinical model of primary effusion lymphoma.
Blood
2009;113;19
Interferon-alpha counteracts the angiogenic switch and reduces tumor cell proliferation in a spontaneous model of prostatic cancer.
Carcinogenesis
2009;30;5
Cross-talk between tumor and endothelial cells involving the Notch3-Dll4 interaction marks escape from tumor dormancy.
Cancer Res.
2009;69;4
Tumor-targeted interferon-alpha delivery by Tie2-expressing monocytes inhibits tumor growth and metastasis.
Cancer Cell
2008;14;4
Hypoxia inducible factor-1alpha inactivation unveils a link between tumor cell metabolism and hypoxia-induced cell death.
Am. J. Pathol.
2008;173;4
[ See timeline ] [ See all publications ]
means that Indraccolo, Stefano has 8 papers cited a least 8 times - methodology
Department of Oncology and Surgical Sciences, University of Padova, Italy.
Due mainly to homonyms, errors are possible and if you detect "false positives" or "false negatives" don't be too frustrated and please contact the webmaster.